Cargando…

Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats

BACKGROUND: Calcineurin (CaN) having a high expression in hippocampal neurons is closely related to apoptosis. Pretreatment with nimodipine can lower the apoptosis rate of hippocampal neuron to reduce the incidence of postoperative cognitive dysfunction (POCD). However, the relationship between cere...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qi, Li, Yanan, Bao, Yongjuan, Yin, Chunping, Xin, Xi, Guo, Yangyang, Gao, Fang, Huo, Shuping, Wang, Xiuli, Wang, Qiujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902967/
https://www.ncbi.nlm.nih.gov/pubmed/29661144
http://dx.doi.org/10.1186/s12871-018-0501-0
_version_ 1783314853920768000
author Zhang, Qi
Li, Yanan
Bao, Yongjuan
Yin, Chunping
Xin, Xi
Guo, Yangyang
Gao, Fang
Huo, Shuping
Wang, Xiuli
Wang, Qiujun
author_facet Zhang, Qi
Li, Yanan
Bao, Yongjuan
Yin, Chunping
Xin, Xi
Guo, Yangyang
Gao, Fang
Huo, Shuping
Wang, Xiuli
Wang, Qiujun
author_sort Zhang, Qi
collection PubMed
description BACKGROUND: Calcineurin (CaN) having a high expression in hippocampal neurons is closely related to apoptosis. Pretreatment with nimodipine can lower the apoptosis rate of hippocampal neuron to reduce the incidence of postoperative cognitive dysfunction (POCD). However, the relationship between cerebral protective effect of pretreatment with nimodipine and CaN is controversial in the literature. The aim of this study is to evaluate the relationship between neuroprotective effect of nimodipine and CaN on POCD in aged rats. METHODS: Ninety-six 18-month-old male Sprague-Dawley rats were randomly assigned into 4 groups (n = 24 each): control group (Group C), nimodipine group (Group N), surgery group (Group S) and nimodipine + surgery group (Group N + S). In Group N and Group N + S, nimodipine 1 mg/kg was intraperitoneally injected, while the equal volume of normal saline was given instead in Group S. 30 min later, Group N and Group C inhaled pure oxygen for 2 h, and Group S and N + S inhaled 3% sevoflurane for 2 h when exploratory laparotomy was performed. Morris water maze test was performed on 1 day before operation and 1, 3 and 7 days after operation. After the end of Morris water maze test at 1 day before operation and 1 and 7 days after operation, 8 rats were sacrificed, brains were removed and hippocampal tissues were obtained for detection of apoptosis in hippocampal neurons, cytoplasmic calcium ([Ca(2+)](i)), and hippocampal CaN and caspase-3 expression. RESULTS: Compared with the 1st day before operation, the escape latency, apoptosis rate, [Ca(2+)](i), expression of CaN and caspase-3 increased significantly, but the frequency of crossing the original platform decreased dramatically in Group S and N + S(P<0.05). In addition, the escape latency, apoptosis rate, [Ca(2+)](i), and expression of CaN and caspase-3 decreased markedly, but the frequency of crossing the original platform increased significantly in Group N + S as compared with Group S (P<0.05). CONCLUSIONS: Pretreatment with nimodipine reduces the incidence of POCD by decreasing CaN mediated hippocampal neuroapoptosis in aged rats.
format Online
Article
Text
id pubmed-5902967
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59029672018-04-23 Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats Zhang, Qi Li, Yanan Bao, Yongjuan Yin, Chunping Xin, Xi Guo, Yangyang Gao, Fang Huo, Shuping Wang, Xiuli Wang, Qiujun BMC Anesthesiol Research Article BACKGROUND: Calcineurin (CaN) having a high expression in hippocampal neurons is closely related to apoptosis. Pretreatment with nimodipine can lower the apoptosis rate of hippocampal neuron to reduce the incidence of postoperative cognitive dysfunction (POCD). However, the relationship between cerebral protective effect of pretreatment with nimodipine and CaN is controversial in the literature. The aim of this study is to evaluate the relationship between neuroprotective effect of nimodipine and CaN on POCD in aged rats. METHODS: Ninety-six 18-month-old male Sprague-Dawley rats were randomly assigned into 4 groups (n = 24 each): control group (Group C), nimodipine group (Group N), surgery group (Group S) and nimodipine + surgery group (Group N + S). In Group N and Group N + S, nimodipine 1 mg/kg was intraperitoneally injected, while the equal volume of normal saline was given instead in Group S. 30 min later, Group N and Group C inhaled pure oxygen for 2 h, and Group S and N + S inhaled 3% sevoflurane for 2 h when exploratory laparotomy was performed. Morris water maze test was performed on 1 day before operation and 1, 3 and 7 days after operation. After the end of Morris water maze test at 1 day before operation and 1 and 7 days after operation, 8 rats were sacrificed, brains were removed and hippocampal tissues were obtained for detection of apoptosis in hippocampal neurons, cytoplasmic calcium ([Ca(2+)](i)), and hippocampal CaN and caspase-3 expression. RESULTS: Compared with the 1st day before operation, the escape latency, apoptosis rate, [Ca(2+)](i), expression of CaN and caspase-3 increased significantly, but the frequency of crossing the original platform decreased dramatically in Group S and N + S(P<0.05). In addition, the escape latency, apoptosis rate, [Ca(2+)](i), and expression of CaN and caspase-3 decreased markedly, but the frequency of crossing the original platform increased significantly in Group N + S as compared with Group S (P<0.05). CONCLUSIONS: Pretreatment with nimodipine reduces the incidence of POCD by decreasing CaN mediated hippocampal neuroapoptosis in aged rats. BioMed Central 2018-04-16 /pmc/articles/PMC5902967/ /pubmed/29661144 http://dx.doi.org/10.1186/s12871-018-0501-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zhang, Qi
Li, Yanan
Bao, Yongjuan
Yin, Chunping
Xin, Xi
Guo, Yangyang
Gao, Fang
Huo, Shuping
Wang, Xiuli
Wang, Qiujun
Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats
title Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats
title_full Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats
title_fullStr Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats
title_full_unstemmed Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats
title_short Pretreatment with nimodipine reduces incidence of POCD by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats
title_sort pretreatment with nimodipine reduces incidence of pocd by decreasing calcineurin mediated hippocampal neuroapoptosis in aged rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902967/
https://www.ncbi.nlm.nih.gov/pubmed/29661144
http://dx.doi.org/10.1186/s12871-018-0501-0
work_keys_str_mv AT zhangqi pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT liyanan pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT baoyongjuan pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT yinchunping pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT xinxi pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT guoyangyang pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT gaofang pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT huoshuping pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT wangxiuli pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats
AT wangqiujun pretreatmentwithnimodipinereducesincidenceofpocdbydecreasingcalcineurinmediatedhippocampalneuroapoptosisinagedrats